NCT00035204

Data

{
  "briefSummary": "The purpose of this study is to evaluate the relative effects of galantamine compared to donepezil (both cholinesteraste inhibitors), on sleep, attention, and gastrointestinal tolerance in patients with Alzheimer's disease.",
  "completionDate": "2003-05",
  "conditions": [
    "Alzheimer Disease"
  ],
  "enrollmentCount": 63,
  "enrollmentType": "ACTUAL",
  "nctId": "NCT00035204",
  "phase": "PHASE4",
  "sponsorId": "johnson-johnson-pharmaceutical-research-development-l-l-c",
  "startDate": null,
  "status": "COMPLETED",
  "studyType": "INTERVENTIONAL",
  "title": "A Double-blind, Randomized Pilot Study to Evaluate the Effects of Galantamine and Donepezil on Sleep and Attention and Gastrointestinal (GI) Tolerance in Patients With Mild to Moderate Alzheimer's Disease (AD)",
  "url": "https://clinicaltrials.gov/study/NCT00035204"
}

History in this collection

1. addedv1.0.0Jun 12, 2026this version